Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
about
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLCTreatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated RadiosurgeryOutcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.Reconstitution of internal target volumes by combining four-dimensional computed tomography and a modified slow computed tomography scan in stereotactic body radiotherapy planning for lung cancerFocal exposure of limited lung volumes to high-dose irradiation down-regulated organ development-related functions and up-regulated the immune response in mouse pulmonary tissues.Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.Molecular and cellular profiling of acute responses to total body radiation exposure in ovariectomized female cynomolgus macaques.Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor.Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitisThe significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancerRadiation pneumonitis after stereotactic radiation therapy for lung cancer.Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.Risk Factors Associated With Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancerDose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy treatment with flattening filter free beams and the potential role of calculation grid sizeUsefulness of target delineation based on the two extreme phases of a four-dimensional computed tomography scan in stereotactic body radiation therapy for lung cancer.Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapyComorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer
P2860
Q29248453-6DD717EF-160D-4FDB-BD48-6A5B947284C9Q30666911-F55A9F67-B35A-4318-9AFC-ABA924F693A9Q33582666-0B924EEF-9E32-4A35-B9D5-E580CBCAC15AQ33602321-C50AF067-339B-421A-8B31-24454358F5DBQ35906384-3E301352-A664-4DD1-A239-B29D61FFD8A9Q35907834-4E7BD5EA-9A1A-4016-A925-75F32AD372ACQ36049704-31D2E676-D32E-4C54-BC76-A9F60707B81DQ36187134-7879FEF0-2799-48F7-8CDD-87928D8FEED9Q36234741-7B9440AD-557F-4CA1-9379-C45B9B50DBD4Q36363955-A3842DCE-3AC7-4B9E-885A-7B1E3A830525Q36550894-8FB488C1-312E-41E8-A39D-EA349AE085B3Q37153781-7A6EE7D3-31F7-4D76-823E-CF98D3F53BB6Q37178916-AF037A92-2143-4127-9460-0D38617401C7Q37458027-5E1E5D5A-8F1C-4729-A2A7-36200BE0ACD3Q37670436-79E9D061-5A16-4BC4-A0BD-153F0DB8FBE7Q38256158-FC2CC3C6-3A19-4546-84B5-DAEDB2C923D5Q38757792-4D6A4FBD-8EC7-40D3-B892-EE100ECCC060Q38871523-413E8E66-1034-4C47-B5CA-4DFF2A866B30Q38914828-A7D6B52E-374F-426A-85CA-8B379E29983AQ39496906-4F57D39D-388A-4F15-A413-3E616B1692A7Q40496623-380B1B88-670C-4E71-8840-3ECCBFE14590Q41052495-30354C76-C1CF-4522-B23C-341A33F516FEQ41335383-07B119A2-1566-4F50-A386-3DAA2A8756AEQ41595091-F1057C8D-E662-4A3A-A2AA-A37E36B450DEQ43756128-2AB28D2E-829C-461D-BA72-9282692C0DA8Q51621075-4A84B750-05B2-4A07-A304-14487ED4F915Q55079973-3BC93400-FD14-4A37-9501-920225C63E4CQ58131311-893D37E0-4937-4260-A7DA-3D51D491E6A5Q58614800-82B9151C-2D9A-4D40-B048-9FD90B23871A
P2860
Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Clinical and dosimetric predic ...... radiation therapy to the lung.
@en
Clinical and dosimetric predic ...... radiation therapy to the lung.
@nl
type
label
Clinical and dosimetric predic ...... radiation therapy to the lung.
@en
Clinical and dosimetric predic ...... radiation therapy to the lung.
@nl
prefLabel
Clinical and dosimetric predic ...... radiation therapy to the lung.
@en
Clinical and dosimetric predic ...... radiation therapy to the lung.
@nl
P2093
P1476
Clinical and dosimetric predic ...... radiation therapy to the lung.
@en
P2093
Carolyn Turke
Craig W Stevens
MaryLou DeMarco
Ryan Baker
Siriporn Sarangkasiri
Thomas J Dilling
P304
P356
10.1016/J.IJROBP.2012.03.041
P407
P577
2012-08-25T00:00:00Z